Skip to main content
. 2017 Mar 15;8(39):66540–66549. doi: 10.18632/oncotarget.16239

Figure 1. Kaplan-Meier estimates depicting the recurrence-free survival (a), cancer-specific survival (b), and overall survival (c) stratified according to preoperative chronic kidney disease status.

Figure 1

a. Recurrence-free survival. Non CKD; median: not available vs. CKD; median: 82.3 months (95% CI: not available), p = 0.001. CKD, chronic kidney disease; CI, confidence interval. b. Cancer specific survival. Non CKD; median: not available vs. CKD; median: not available, p = 0.001. CKD, chronic kidney disease. c. Overall survival. Non CKD; median: 105 months (95% CI: 88.1–not available) vs. CKD; median: 58.0 months (95% CI: 48.9– not available), p = 0.001. CKD, chronic kidney disease; CI, confidence interval